Prevention of Prescription Opioid Drug Abuse and Misuse—Prescription Drug Monitoring Programs
In this series of reviews, OIG reviewed actions that selected States have taken, using Federal funds for enhancing prescription drug monitoring programs (PDMPs), to achieve program goals toward improving safe prescribing practices and preventing prescription drug abuse and misuse. OIG also determined whether the States complied with certain Federal requirements. This series includes States that have had a high number of overdose deaths, have had a significant increase in the rate of drug overdose deaths, or have received HHS funding to enhance their PDMPs.
View this series in a text-based format.
Last Updated January 12, 2021